Gael Chetelat

Summary

Affiliation: GIP Cyceron
Country: France

Publications

  1. ncbi Relationship between atrophy and beta-amyloid deposition in Alzheimer disease
    Gael Chetelat
    Department of Nuclear Medicine and Center for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Ann Neurol 67:317-24. 2010
  2. ncbi Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
    Victor L Villemagne
    Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Australia
    Ann Neurol 69:181-92. 2011
  3. ncbi Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease
    Gael Chetelat
    Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia
    Brain 134:798-807. 2011
  4. ncbi Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study
    Kerryn E Pike
    Department of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Vic, Australia
    Neuropsychologia 49:2384-90. 2011
  5. ncbi Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease
    Gael Chetelat
    Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Vic, Australia
    Neurodegener Dis 10:141-4. 2012
  6. ncbi Larger temporal volume in elderly with high versus low beta-amyloid deposition
    Gael Chetelat
    Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia
    Brain 133:3349-58. 2010
  7. ncbi In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease
    Victor L Villemagne
    Department of Nuclear Medicine, Centre for Positron Emission Tomography, Austin Hospital, Austin Health, Heidelber, Australia
    Arch Neurol 68:905-12. 2011
  8. ncbi Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
    P A Yates
    Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Neurology 77:48-54. 2011
  9. ncbi Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study
    Alex Bahar-Fuchs
    Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
    J Alzheimers Dis 22:1081-7. 2010
  10. ncbi Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
    Alex Bahar-Fuchs
    Department of Nuclear Medicine, Centre for PET, Austin Health, Melbourne, Vic, Australia
    J Alzheimers Dis 33:451-62. 2013

Detail Information

Publications10

  1. ncbi Relationship between atrophy and beta-amyloid deposition in Alzheimer disease
    Gael Chetelat
    Department of Nuclear Medicine and Center for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Ann Neurol 67:317-24. 2010
    ..The present study aims to assess this relationship...
  2. ncbi Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
    Victor L Villemagne
    Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Australia
    Ann Neurol 69:181-92. 2011
    ..Assess Aβ deposition longitudinally and explore its relationship with cognition and disease progression...
  3. ncbi Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease
    Gael Chetelat
    Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia
    Brain 134:798-807. 2011
    ....
  4. ncbi Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study
    Kerryn E Pike
    Department of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Vic, Australia
    Neuropsychologia 49:2384-90. 2011
    ..The finding of gender differences deserves further research to answer definitively the important question of gender susceptibility to adverse cognitive effects from β-amyloid...
  5. ncbi Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease
    Gael Chetelat
    Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Vic, Australia
    Neurodegener Dis 10:141-4. 2012
    ..The development of Aβ ligands for in vivo PET imaging has greatly facilitated the assessment of this question...
  6. ncbi Larger temporal volume in elderly with high versus low beta-amyloid deposition
    Gael Chetelat
    Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia
    Brain 133:3349-58. 2010
    ..Our complementary analyses tend to support the latter hypotheses. Overall, our findings suggest that the deleterious effects of β-amyloid on cognition may be delayed in those subjects with larger brain (temporal) volume...
  7. ncbi In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease
    Victor L Villemagne
    Department of Nuclear Medicine, Centre for Positron Emission Tomography, Austin Hospital, Austin Health, Heidelber, Australia
    Arch Neurol 68:905-12. 2011
    ..Design, Setting, and..
  8. ncbi Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
    P A Yates
    Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Neurology 77:48-54. 2011
    ..We hypothesized that Aβ deposition in asymptomatic elderly individuals is associated with lobar MH (LMH)...
  9. ncbi Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study
    Alex Bahar-Fuchs
    Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
    J Alzheimers Dis 22:1081-7. 2010
    ..We conclude that AD-related olfactory identification deficits are not directly related to Aβ burden...
  10. ncbi Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
    Alex Bahar-Fuchs
    Department of Nuclear Medicine, Centre for PET, Austin Health, Melbourne, Vic, Australia
    J Alzheimers Dis 33:451-62. 2013
    ..In conclusion, a measure of story recall may increase the confidence in making a diagnosis of MCI due to AD in clinical settings...